05503841 is referenced by 35 patents and cites 7 patents.

Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine employ IL-2 as an active ingredient, preferably human IL-2.

Title
Human IL-2 as a vaccine adjuvant
Application Number
778372
Publication Number
5503841
Application Date
February 24, 1989
Publication Date
April 2, 1996
Inventor
Thomas J White
Oakland
CA, US
Jack H Nunberg
Oakland
CA, US
Arthur D Newell
Orinda
CA, US
Michael V Doyle
Oakland
CA, US
Agent
Robert P Blackburn
Thomas C Meyers
Barbara G McClung
Assignee
Cetus Oncology Corporation
CA, US
IPC
A61K 39/12
A61K 39/02
A61K 38/20
View Original Source